Test for the determination of human autoantibodies against recoverin, to support the diagnosis of paraneoplastic neurological syndromes.
Test for the determination of human autoantibodies against PNMA2 (Ma-2/Ta) to support the diagnosis of paraneoplastic neurological syndromes with a high-risk phenotype.
Test for the determination of human autoantibodies against ITPR1.
Test for the determination of human autoantibodies against Hu (ANNA-1) to support the diagnosis of paraneoplastic neurological syndromes with a high-risk phenotype.
Test for the determination of human autoantibodies against GAD65 to support the diagnosis of low-risk paraneoplastic neurological syndromes.
Test for the determination of human autoantibodies directed against DNER (also known as Tr) to support the diagnosis of paraneoplastic neurological syndromes with a high-risk phenotype.
Test for the determination of human autoantibodies against CARP (carbonic anhydrase–related protein VIII).
Test for the determination of human autoantibodies against the receptor AMPA1/2to support the diagnosis of paraneoplastic neurological syndromes with an intermediate-risk phenotype.
Subscribe to our newsletter to be always updated.